Real-time enrollment status for this pharmacokinetics after oral intake clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:51 PM UTC
| NCT Number | NCT07092813 |
| Recruiting Status | Recruiting |
| Condition | Pharmacokinetics After Oral Intake |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Iterum Therapeutics, International Limited |
| Last Updated on CT.gov | March 27, 2026 (Mar 27, 2026) |
As of July 19, 2026: Clinical trial NCT07092813 is currently recruiting participants. This phase1 study for pharmacokinetics after oral intake is actively seeking new participants at 1 location across the United States. The study is sponsored by Iterum Therapeutics, International Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07092813 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07092813 was last updated Mar 27, 2026 (March 27, 2026). HelloStudys verifies this status automatically.